1AE:ETR
argenx SE
718,80 €
arrow_downward
-1,88%(-13,80) 1D
13 հոկ, 17:35:47 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1AE...
Open
736,60 €
High
744,00 €
Low
718,80 €
Mkt. cap
46,28 մլրդ
Avg. vol.
82,00
Volume
247,00
P/E ratio
30,59
52-wk high
922,00 €
52-wk low
574,20 €
EPS
23,50 €
No. of employees
2 հզր
Open
736,60 €
High
744,00 €
Low
718,80 €
Mkt. cap
46,28 մլրդ
Avg. vol.
82,00
Volume
247,00
P/E ratio
30,59
52-wk high
922,00 €
52-wk low
574,20 €
EPS
23,50 €
No. of employees
2 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
9 ժամ առաջ
Baird cuts target for Argenx stock to USD 823.00
ad-hoc-news.de
·
1 օր առաջ
Argenx stock at EUR 745.20, 0.05 percent below its recent high
ad-hoc-news.de
·
1 օր առաջ
Argenx halts UNITY study. Argenx stock trades 1.18 percent higher
ad-hoc-news.de
·
1 օր առաջ
argenx stock pre-market at EUR 734.10
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE